Schwarz Pharma's foray into the central nervous system
disorder market is beginning to pay serious dividends as the
firm's ground-breaking transdermal patch for Parkinson's continues
to prove a success story, now gaining...
Researchers have taken a special interest in mechanisms they have
identified as an explanation for the causes of Parkinson's disease,
which they say, may facilitate research aimed at finding novel
medical treatments and other...
A new therapy for Parkinson's disease involving brain implants has
been developed by US scientists, who believe this new treatment is
a viable alternative to drugs currently used to treat this chronic
irreversible brain condition.
Researchers have discovered a new mechanism that reveals how high
levels of a neurotransmitter exerts its effect on the brain. The
findings provide new research avenues to understand and potentially
CeNeS Pharmaceuticals and Tripos have entered into a new agreement
to continue their collaboration on COMT inhibitors, which represent
a new breed of therapy for Parkinson's disease and other psychotic
disorders such as schizophrenia.
Scientists researching pharmaceutical treatments for Parkinson's
disease are invited to submit study information to a new patient
website, which is intended to improve access to information on
Parkinson's clinical trials,...
The next generation of orally-active erectile dysfunction (ED)
drugs took a step closer as researchers isolated a receptor that
could be used as a target of drug treatment without the side
effects associated with the only approved...
A team of scientists in the US have identified a molecular target
in which could herald the formation of the first pharmacological
therapy for treating amphetamine addiction, which is estimated to
affect around 9 million Americans,...